A vast array of thiazole derivatives having excellent broad spectrum activity forms an invaluable part of the present armory of the clinicians. The synthesis and antibacterial activity of several new ethyl 2-amino-4-methylthiazole-5-carboxylate(1) 5 derivatives substituted at 2 nd position by aryl aldehydes of the thiazole moiety have shown some to increase the antibacterial activity of thiazole. In this study we thought to synthesize thiazole system incorporating substituted aryl aldehydes. The most active compound was 4-methyl-5-hydrazine hydrate-2-(4-methoxy-3-hydroxy benzene) methyleneamino thiazole-5-carboxylate (3c) equipotent to Ciprofloxacin.C 2 position of thiazole ring requires large hydrophilic, electronegative functional moieties like substituted phenyl ring etc for enhanced antibacterial activity of thiazole. In our compounds alkyl (methyl) group is present, still most of the compounds show good antibacterial activity.C 5 position of thiazole ring requires small hydrophobic, electronegative functional moieties like amino, hydrazine hydrate attach with ester for antibacterial activity of thiazole in general.
INTRODUCTION
Research over the past 50 years has been focused on meeting medical needs to treat infectious disease caused by life threatening pathogens. In spite of the introduction of a variety of antibacterial agents in multiple unrelated drug classes, resistance continues to emerge. The pharmaceutical field (including academic) must respond to these clinical challenges by bringing forward a stream of new agents with promising antibacterial activity against bacteria, Advantages of these agents include their higher predictability for success, well-defined biomarkers, shorter clinical trials, and shorter duration of therapy leading to fewer long-term safety concerns 24 . Due to the rapid development of bacterial resistance to antibacterial agents, it is vital to discover novels scaffold for the design and synthesis of the new antibacterial agents to help in the battle against pathogenic microorganisms. Much research has been carried out with the aim to discover the therapeutic values of thiazole derivatives. . A number of these compounds are today's blockbusters of the antibacterial market due to their therapeutic efficacy having tolerable side-effects and thus, challenging the predominance of well established β-lactum antibiotics which are becoming more prone to the resistant pathogenic bacteria 
RESULTS AND DISCUSSION
Reviewing of the antibacterial activities of compounds (3a-c), with the exception of activity of the compounds (3a) and (3b) against E.coli, compound (3c) was found to be equipotent to
Ciprofloxacin. In case of antibacterial activity against S.aureus compound (3c) was found to be more active than ciprofloxacin whereas compounds (3a) and (3b) were found to be moderately active to that of ciprofloxacin. When evaluation of the compounds against P.aeruginosa was done it was found compound (3c) was more active than ciprofloxacin and compounds (3a) and (3b) were found to be moderately active. Antibacterial activity against B. subtilis compounds (3a) and (3b) were found to be moderately active whereas (3c) was found to be more potent to that of Ciprofloxacin.
As was anticipated it was found out that The most active compound in the series was found out to be (3c) with the exception of activity equipotent to Ciprofloxacin against E.coli. The activity was found to be more as compared to ciprofloxacin against all tested organisms particularly, S.aureus, P.aeruginosa, B.subtilis.
Compounds (3b) and (3c) showed moderate activity as compared to ciprofloxacin. The compounds in the series were active against both gram negative and gram positive bacteria.
EXPERIMENTAL
All the chemicals for the synthesis were purchased from approved vendors of different make like Aldrich, Loba, Spectrochem and all chemicals were of laboratory grade. Completion of reaction were confirmed using physical constant determination (Sharp or narrow melting ranges, physical constants were not matching any of the reactants/starting material/s).Melting points were determined using Labin Melting Point Apparatus in open capillaries and are uncorrected.
Further the compounds synthesized were proceeded for TLC wherein single spots (1   st   TLC run) were observed, indicating completion of reaction. After work-up was completed, (unreacted starting materials were removed), the products were subjected to purification by recrystallization process. Again TLC was run to find out exact R f value. TLC plates used for final recrystallized product were pre-coated silica gel G plates. Solvent systems were developed using trial and error method by use of appropriate solvents of different polarity .FT-IR spectra were recorded using 
N.S. = Not Sensitive
Cip -Ciprofloxacin. 3a -4-methyl-5-hydrazine hydrate-2-(3,4,5 trimethoxy benzyl methyleneamino) thiazole-5-carboxylate. 3b -4-methyl-5-hydrazine hydrate-2-(m-phenoxy benzyl methyleneamino) thiazole-5-carboxylate 3c-4-methyl-5-hydrazine hydrate-2-(4-hydroxy-3-methoxy benzyl methyleneamino) thiazole-5-carboxylate 
